Related Experiment Video
Updated: Sep 5, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Feeling the tension: Engineered stem cells convert tumor stiffness into a drug target
1Department of Biomedical Engineering, Columbia University, New York, NY, USA.
Abstract:
Radiopharmaceutical theranostics remains constrained by tumors lacking a validated molecular target. Yang et al.1 engineer mesenchymal stem cells that sense tumor stiffness and respond by manufacturing a synthetic target in situ, making PET imaging and radionuclide therapy possible with existing clinical radioligands in tumors that were previously untargetable.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
